Back to articles

Triple therapy in a single inhaler is effective for COPD


Use of a single inhaler containing “triple” therapy with extrafine beclomethasone, formoterol, and glycopyrronium was superior to tiotropium in reducing the rates of moderate to severe exacerbations and improving forced expiratory volume in 1 second (FEV1) in patients with chronic obstructive pulmonary disease (COPD), according to results of the TRINITY study published online in Lancet.